[Should Helicobacter pylori infection be taken into account in the use of nonsteroidal anti-inflammatory agents?].

MLA

Bretagne, J. F., et al. “[Should Helicobacter Pylori Infection Be Taken into Account in the Use of Nonsteroidal Anti-Inflammatory Agents?].” Gastroenterologie Clinique et Biologique, vol. 23, no. 10 Pt 2, Oct. 1999, pp. C48–64. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=10880915&authtype=sso&custid=ns315887.

APA

Bretagne, J. F., Pagenault, M., Bourienne, A., & Heresbach, D. (1999). [Should Helicobacter pylori infection be taken into account in the use of nonsteroidal anti-inflammatory agents?]. Gastroenterologie Clinique et Biologique, 23(10 Pt 2), C48–C64.

Chicago

Bretagne, J F, M Pagenault, A Bourienne, and D Heresbach. 1999. “[Should Helicobacter Pylori Infection Be Taken into Account in the Use of Nonsteroidal Anti-Inflammatory Agents?].” Gastroenterologie Clinique et Biologique 23 (10 Pt 2): C48–64. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=10880915&authtype=sso&custid=ns315887.